SEARCH

SEARCH BY CITATION

References

  • Abel L, Sanchez FO, Oberti J et al. (1998) Susceptibility to leprosy is linked to the human NRAMP1 gene. The Journal of Infectious Diseases 177, 133145.
  • Akilov OE, Amor K & Tayyaba H (2007) Clinical manifestations and classification of Old World cutaneous leishmaniasis. International Journal of Dermatology 46, 132142.
  • Barrett JC, Fry B, Maller J & Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263265.
  • Blackwell JM (1999) Tumour Necrosis Factor alpha and Mucocutaneous Leishmaniasis. Parasitology Today 15, 7375.
  • Bouma G, Crusius JBA, Pool MO et al. (1996) Secretion of Tumour Necrosis Factor α and Lymphotoxin α in Relation to Polymorphisms in the TNF Genes and HLA-DR Alleles. Relevance for Inflammatory Bowel Disease. Scandinavian Journal of Immunology 43, 456463.
  • Cabrera M, Shaw MA, Sharples C et al. (1995) Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. Journal of Experimental Medicine 182, 12591264.
  • Castes M, Trujillo D, Rojas ME et al. (1993) Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Biological Research 26, 233238.
  • Dissanayake VHW, Weerasekera LY, Gammulla CG & Jayasekara RW (2009) Prevalence of genetic thrombophilic polymorphisms in the Sri Lankan population -- implications for association study design and clinical genetic testing services. Experimental and Molecular Pathology 87, 159162.
  • Esposito L, Hill NJ, Pritchard LE et al. (1998) Genetic analysis of chromosome 2 in type 1 diabetes: analysis of putative loci IDDM7, IDDM12, and IDDM13 and candidate genes NRAMP1 and IA-2 and the interleukin-1 gene cluster. Diabetes 47, 17971799.
  • Gauderman WJ & Morrison JM (2007) Quanto 1.2.3: a computer program for power and sample size calculations for genetic-epidemiology studies Available at: http://hydra.usc.edu/gxe (accessed 1 September 2009).
  • Hajeer AH & Hutchinson IV (2000) TNF-alpha gene polymorphism: clinical and biological implications. Microscopy Research and Technique 50, 216228.
  • Handman E, Elso C, Foote S, Baker JR, Muller R & Rollinson D (2005) Genes and Susceptibility to Leishmaniasis. Advances in Parasitology 59, 175.
  • Herwaldt BL (1999) Leishmaniasis. The Lancet 354, 11911199.
  • Kamali-Sarvestani E, Rasouli M, Mortazavi H & Gharesi-Fard B (2006) Cytokine gene polymorphisms and susceptibility to cutaneous leishmaniasis in Iranian patients. Cytokine 35, 159165.
  • Karplus TM, Jeronimo SMB, Chang H et al. (2002) Association between the tumor necrosis factor locus and the clinical outcome of leishmania chagasi infection. Infection and Immunity 70, 69196925.
  • Karunaweera ND, Pratlong F, Siriwardane HVYD, Ihalamulla RL & Dedet JP (2003) Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 380381.
  • Kotze MJ, De Villiers JNP, Rooney RN et al. (2001) Analysis of the NRAMP1 gene implicated in iron transport: association with multiple sclerosis and age effects. Blood Cells, Molecules, and Diseases 27, 4453.
  • Lara ML, Layrisse Z, Scorza JV et al. (1991) Immunogenetics of human american Cutaneous Leishmaniasis: study of HLA haplotypes in 24 families from Venezuela. Human Immunology 30, 129135.
  • Liu J, Fujiwara TM, Buu NT et al. (1995) Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. American Journal of Human Genetics 56, 845853.
  • Messer G, Spengler U, Jung MC et al. (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF- beta production. Journal of Experimental Medicine 173, 209219.
  • Mohamed HS, Ibrahim ME, Miller EN et al. (2003) SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan. European Journal of Human Genetics 12, 6674.
  • Murphy KM, Travers P & Walport M (2007) Innate immunity. In: Janeway’s Immunobiology, 7th edn. Garland Science, London, pp. 39103.
  • Peacock CS, Seeger K, Harris D et al. (2007) Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nature Genetics 39, 839847.
  • Pociot F, Briant L, Jongeneel CV et al. (1993) Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. European journal of Immunology 23, 224231.
  • Roberts LJ, Handman E & Foote SJ (2000) Science, medicine, and the future: leishmaniasis. British Medical Journal 321, 801804.
  • Rodríguez MR, González-Escribano MF, Aguilar F, Valenzuela A, García A & Núñez-Roldán A (2002) Association of NRAMP1 promoter gene polymorphism with the susceptibility and radiological severity of rheumatoid arthritis. Tissue Antigens 59, 311315.
  • Samaranayake TN, Dissanayake VHW & Fernando SD (2008) Clinical manifestations of cutaneous leishmaniasis in Sri Lanka possible evidence for genetic susceptibility among the Sinhalese. Annals of Tropical Medicine and Parasitology 102, 383390.
  • Shaw MA, Collins A, Peacock CS et al. (1997) Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: linkage study of the candidate genes NRAMP1 and TNFA. Tubercle and Lung Disease 78, 3545.
  • Wattavidanage J, Carter R, Perera KLRL et al. (1999) TNFa*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans. Clinical & Experimental Immunology 115, 350355.
  • WHO (2007) Report of the Consultative Meeting on Cutaneous Leishmaniasis. Geneva, WHO Headquarters.
  • WHO (2009) Leishmaniasis, Burden of Disease. URL: Available at: http://www.who.int/leishmaniasis/burden/en/ (accessed 1 October 2009).